维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="Klade"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Therapeutic vaccinationof chronic hepatitis C nonresponder patients with the peptidevaccine IC41 显示文摘	Klade CS Wedemeyer H Berg T	2008	Gastroenterology2008，134，5：	1
2	Identification of tumor antigens in renal cell carcinoma by serological proteome analysis 显示文摘	KLADE C S VOSS T KRYSTEK E	2001	Proteomics2001，1，7：	1
3	Identification of tumor antigens in renal cell carcinoma by serological proteome analysis显示文摘	Klade C S Voss T Krystek E	2001	Proteomics2001，1，7：	1
4	Identification of tumor antigens in renal cell carcinoma by serological proteome analysis显示文摘	Klade CS Voss T Krystek E	2001	Proteomics2001，1，7：	1
5	Identification of tumor antigens in renal cell carcinoma by serological proteome analysis显示文摘	Voss T Krystek E	2001	Proteomics2001，1，7：	1
6	Experimental discovery of T- cell epitopes: combining the best of classical and contem- porary approaches 显示文摘	Scharnagl N C Klade C S	2007	Expert Rev Vaccines2007，6，4：	1
7	Identification of tumor antigens in renal cell carcinoma by serological proteome analysis显示文摘	Klade CS Voss T Krystek E	2001	Proteomics2001，1，7：	1
8	Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived,inactivated Japanese encephalitis virus vaccine candidate IC51显示文摘	Schuller E Klade C S Heinz F X	2008	Vaccine2008，26，：	1
9	Identification of tumor antigens in renal cell carcinoma by serological proteome analysis显示文摘	Voss T Krystek E	2001	Proteomics2001，1，7：	1
10	lmmunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) pep- tide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects 显示文摘	Firbas C Jilma B Tauber E Buerger V Jelovcan S Ling- nau K Buschle M Frisch J Klade CS	2006	Vaccine2006，24，20：	1
11	Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41 显示文摘	Klade CS Wedemeyer H Berg T Hinrichsen H Chol- ewinska G Zeuzem S Blum H Buschle M Jelovcan S Buerger V Tauber E Frisch J Manns MP	2008	Gastroenterology2008，134，5：	1
12	Proteomics approaches towards antigen discovery and vaccine development 显示文摘		2002	Curr Opin Mol Ther2002，4，3：	1
13	Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C 显示文摘	Wedemeyer H Schuller E Schlaphoff V Stauber RE Wiegand J Schiefke I Firbas C Jilma B Thursz M Zeuzem S Hofmann WP Hinrichsen H Tauber E Manns MP Klade CS	2009	Vaccine2009，27，37：	1
14	Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO) induced neutralizing antibody liters 显示文摘	Van Gessel Y Klade CS Putnak R	2011	Vaccine2011，29，35：	1
15	Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41显示文摘	Christoph S. Klade Heiner Wedemeyer Thomas Berg Holger Hinrichsen Grazyna Cholewinska Stefan Zeuzem Hubert Blum Michael Buschle Sandra Jelovcan Vera Buerger Erich Tauber Juergen Frisch Michael P. Manns	2008	Gastroenterology2008，，5：	1
16	Therapeutic vacci- nation of chronic hepatitis C nonresponder patients with the peptide vaccine IC41 显示文摘	Klade CS Wedemeyer H Berg T	2008	Gastroenterology2008，134，：	1
17	The yeast growth control gene GRC5 is highly homologous to the mammalian putative tumor suppressor gene QM 显示文摘	Klade T Ellinger A	1996	Yeast1996，12，：	1
18	Identification of tumor antigens in renal cell carcinoma by serological proteome analysis显示文摘	Klade CS Voss T Krystek E	2001	Proteomics2001，1，7：	1
19	Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41显示文摘	Klade C S Wedemeyer H Berg T		0，，05：	1
20	Identification of tumor antigens in renal cell carcinoma by serological proteome analysis 显示文摘	Klade C S Voss T Krystek E	2001	Proteomics2001，1，7：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示